Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Finasteride may cause kidney damage.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Androgens increase cervical cancer risk and affect its development.

Analog 23 is a promising compound for prostate cancer treatment.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Sesamin may help treat hair loss by affecting specific cell pathways.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

High TNF-α levels may increase hair loss risk after PRP therapy.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.